New Jefferson CEO Appointed

On behalf of the Board of Trustees, we are thrilled to share the news that after a competitive national search, we have appointed Joseph G. Cacchione, MD as the incoming enterprise-wide CEO of Thomas Jefferson University and Jefferson Health, effective September 6, 2022.

We have found a remarkable leader, and we will be making this announcement today. Dr. Cacchione comes from Ascension Health, one of the largest nonprofit healthcare systems in the U.S., where he has served as an integral leader since 2017. Most recently, Dr. Cacchione served as Executive Vice President, Clinical and Network Services (CNS), for Ascension Health, a $28B organization with 165,000 employees across 145 hospitals and 2,600+ care sites in 19 states and the District of Columbia. Before his current role, he served as CEO of Ascension Michigan with 15 hospitals and 22,000 employees.

While at Ascension, he was instrumental in building the new strategic plan focused on moving to differentiated quality, value, and consumer centricity. He also led Ascension’s enterprise initiative to centralize operations and created an operating company with a common purpose and mission. He has helped develop and launch proprietary accountable care organizations to address the needs of uninsured patients and created multiple programs to help increase health equity.

Joseph G. Cacchione

Joseph G. Cacchione

 Before his time at Ascension Health, Dr. Cacchione spent eight years at the Cleveland Clinic, a leading academic medical center that integrates clinical and hospital care with research and education, where he played a major enterprise role in business development while also serving as Chairman of Operations and Strategy for its Heart and Vascular Institute. And, before that, he spent 20 years as a private practice cardiologist and large private physician practice executive. The depth and breadth of Dr. Cacchione’s previous experience in different markets and business conditions—as well as his demonstrated commitment to DEI both internal to his team and organization and with respect to health and academic equity—make him well-suited to lead Jefferson as it continues to shape the future of healthcare, higher education, and research.

The naming of Dr. Cacchione as the Jefferson enterprise CEO is part of the Board’s development of a new senior executive operating model. Jefferson Health President Bruce A. Meyer, MD, MBA, and Thomas Jefferson University President Mark L. Tykocinski, MD will both report directly to Dr. Cacchione. We believe this new model will further the enterprise mission to improve lives and to reach new heights in higher education, research, and clinical care.

We are grateful to Rich Haverstick for his tireless work as the interim leader of Jefferson since January of this year. Rich has provided the continuity to keep Jefferson moving forward during this time of transition. He has graciously agreed to assist with Dr. Cacchione’s onboarding through December. Chief Human Resource Officer Clayton Fitzhugh has also agreed to lead the transition team for Dr. Cacchione. He will work closely with us, Rich, and Dr. Cacchione to ensure a smooth transition.

We are also grateful to the CEO Search Committee who, together with Egon Zehnder, led this national search and dedicated themselves to identifying and assessing feedback from more than 450 people. This has been the most extensive and inclusive assessment process Jefferson has ever engaged in for a leadership search. We cannot thank them enough for their commitment and thoughtful approach.

The result of this teamwork and collaboration is a CEO who embodies the spirit and mission of Jefferson and will strategically lead us into the future of higher education and healthcare. 

Recent Posts

Triple Valve Surgery and Atrial Fibrillation

Triple Valve Surgery and Atrial Fibrillation

Atrial fibrillation is often described as either valvular AFib or nonvalvular AFib. AFib is considered valvular when seen in patients who have a heart valve disorder or a prosthetic heart valve in place. Nonvalvular AFib maybe caused by medical disorders such as high...

read more
Respiratory Care Week

Respiratory Care Week

Respiratory Care Week is a special time to honor the hard work and dedication of respiratory therapists. Their impact on patient care is truly invaluable. As key members of our collaborative heart team, they play a crucial role in caring for our post-operative...

read more
Beautiful Hospitals Impact Healing

Beautiful Hospitals Impact Healing

I’ve been fortunate to work at aesthetically beautiful hospitals for my entire career. It’s important to understand that beautifully-designed hospital spaces do have a positive impact on healing, from allowing in natural light, to the construction of healing gardens...

read more
How Safe are GLP Medications?

How Safe are GLP Medications?

Drugs known as GLP-1 medications are being widely prescribed in the United States. The most well-known are Mounjaro, Ozempic, Wegovy, Cagrisema, and Rybelsus. In this video, I explained the basics, including how they work, their impact on the heart, and some of their...

read more
Tricuspid Valve Repair

Tricuspid Valve Repair

With permission from the patient to post, this active 77-year-old man from Carlisle, Pennsylvania, was troubled by severe tricuspid valve regurgitation secondary to chronic atrial fibrillation. His symptoms included extreme tiredness, shortness of breath with...

read more
4th Annual Philadelphia CardioVascular Congress

4th Annual Philadelphia CardioVascular Congress

My colleague and friend, Dr. Konstadinos Plestis invites you to join us at the 4th Annual Philadelphia Cardiovascular Conference, to be held on Thursday, October 24 - Friday, October 25, 2024 at the Bellevue Hotel, Philadelphia, Pennsylvania. CLICK HERE to learn...

read more

Featured

Pages

Questions? Comments?
Reach out to me here:

11 + 8 =

About The Author

Dr. Raymond Singer

Dr. Singer has been in practice since 1992 and has, to date, performed over 8000 surgeries. His practice interests include complex valve, coronary and aneurysm surgery, as well as prevention and treatment of lung cancer.


Top Doctors - 2021